THERMAWe appreciate everyone’s support and patience and emphasize we are on track, as per previous releases, in terms of continuing our discussions with government agencies and advancing our clinical validations. Although we encourage communication between our shareholders and ourselves, the volume of emails we are receiving will not accelerate the process.
To be clear, we are on track and will release news at the appropriate time.